Key player · Company profile

Cepheid

Named as a key player in 66 of our reports, across 33 regions and countries.

Fastest-growing markets they play in

2023–2033 CAGR · estimates

  1. 1Point Of Care (PoC) Molecular Diagnostic (India) 12.3%
  2. 2Point of Care Diagnostics (India) 10.4%

Where they show up

  • Digital Health33
  • Healthcare Services33

Geographies

Cepheid's markets

Markets where Cepheid is a key player, with the world market size
MarketCategoryWorld 2023CAGR
Point of Care Diagnostics Digital Health$45.4 Bn7.4%
Point Of Care (PoC) Molecular Diagnostic Healthcare Services$18.7 Bn9.3%

Companies they compete with most

Named as key players in the same markets as Cepheid (number of shared markets).

Abbott Laboratories2 shared markets bioMérieux SA2 shared markets Quidel Corporation2 shared markets Roche Diagnostics2 shared markets Siemens Healthineers2 shared markets Becton, Dickinson and Company (BD)1 shared market Danaher Corporation1 shared market Grifols1 shared market

Recent reports naming Cepheid

Search all reports for Cepheid All companies